BIOCON SHORT TERMBIocon is engaged in the business of manufacture of biotechnology products and research services.
BIOCONM2024 trade ideas
Beautiful example of the power of ICT analysisThis was the first Indian futures product I looked at after a friend asked me for an analysis. Lots and lots to study and see.
Biocon potential up move for 25 points. level 270Strong up side move, Respect Fibo levels. Potential up move started after corrections.
Biocon retracing from support zone1. RSI positive divergance in 30 min
2. pharma seems strong up coming days
3. now at support of weekly pivot
BIOCONVolumes that have come in today are better than the average volumes, and even the data shows some good upmove.
This can be a long with stop loss of 398-400 for a target of 412, 418 and 425
************************************************************************************************************************************************
Hi all,
Its pleasure to have you all here.
I have started putting these charts as a contribution from my side to all people who are new to business, as I had to struggle a lot without any sources at disposal. So please consider this a just small contribution from my side.
Few Honest Disclosures:
1. Any idea shared is my personal view, its not a recommendation, neither any kind of paid propaganda, so please
do your bit of research.
2. Ideas shared does not mean that I trade all or have position in them, this is just a helping hand to all.
3. I expect no comments or like nor any negativity, as I said its just a small helping hand from my side, please plan your risk and trade as per your capacity.
4. To trade in Cash, options or futures is your sole choice and your own risk
5. I am no expert in Tech Indicators, I believe in support resistance and trendline theory, you may use this as a supplement theory for better results.
6. I work for my own living, this is a hobby which I do sincerely to help anyone who might come across my charts.
***********************************************************************************************************************************************
